The University of Texas MD Anderson Cancer Center will host free skin cancer screenings from 10 a.m. – 1 p.m. on Saturday, May 5 at two of its Houston-area locations.
As part of the annual event sponsored by the Houston Dermatological Society, MD Anderson physicians and area dermatologists will provide free skin checks at:
MD...

Founding TMC3 institutions – Texas Medical Center (TMC), Baylor College of Medicine, Texas A&M University Health Science Center, The University...
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable...
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many patients become resistant to treatment. A team at The University of Texas MD Anderson led a study which may explain how resistance evolves over time, and potentially which patients could benefit from chemotherapy.

Richard D. Wood, Ph.D., professor at The University of Texas MD Anderson Cancer Center, has been elected as a member of the American Academy...
A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the...
Just like people, some T cells have excellent memories. These subtypes known as memory T cells may explain why some immunotherapies are more...
Special Note: All prom events are open to media, including the dress and tux selection, and hair and makeup appointments.
The...
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation...
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug...